Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces
<p>Abstract</p> <p>Background</p> <p>Confidential product listing agreements (PLAs) negotiated between pharmaceutical manufacturers and individual health care payers may contribute to unwanted price disparities, high administrative costs, and unequal bargaining power wi...
Saved in:
Main Authors: | Morgan Steven G (Author), Thomson Paige A (Author), Daw Jamie R (Author), Friesen Melissa K (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploration of inter-jurisdictional TB programming and mobility in a Canadian First Nation community
by: Apeksha Heendeniya Vidanaral, et al.
Published: (2022) -
A Review of "Optimal Fallow Period" Guidance Across Canadian Jurisdictions
by: Sonica Singhal, et al.
Published: (2022) -
Moving towards Universal Coverage of Direct-Acting Antiviral Therapies for Hepatitis C Infection in Canada: An Environmental Scan of Canadian Provinces and International Jurisdictions
by: Samantha Myers, et al.
Published: (2018) -
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders
by: Thompson M, et al.
Published: (2016) -
Inter-Observer Agreement in Headache Diagnosis
by: J Gordon Millichap
Published: (1994)